Cost-effectiveness in diagnosis and treatment of carcinomas of unknown primary origin;Analyse coût/efficacité de la prise en charge diagnostique et thérapeutique des carcinomes d'origine indéterminée

Bulletin du Cancer

Volumn 88, Issue 11, 2001, Pages 1119-1127

  Desboeuf, K ^a   Molinier, L ^a   Carrere M O ^a   Bugat, R ^a   Boisseau, M ^a   Machelard Sauvage, M ^a   Voigt, J J ^a   Pous, J ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Carcinomas of unknown primary origin; Cost effectiveness analysis; Diagnostic strategy.

Indexed keywords

ADULT; AGED; ARTICLE; CANCER; CANCER DIAGNOSIS; CANCER THERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ACCURACY; FEMALE; FRANCE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; METASTASIS; QUALITY OF LIFE; STANDARDIZATION; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0035672619     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Identifying the primary site in metastatic cancer of unknown origin: Inadequacy of roentgenographic procedures
2. Unknown primary tumours
3. Diagnosis and treatment of unknown primary tumors
4. Treatment of the patient with adenocarcinoma of unknown origin
5. Metastatic carcinomas from occult primary tumors: A study of 254 patients
6. Metastatic adenocarcinomas of unknown primary site: A randomized study of two combination-chemotherapy regimens
7. Adénocarcinomes à localisation primitive occulte. À propos d'une série de soixante-dix-huit cas
8. Treatment and prognosis of metastatic carcinoma of unknown primary: Analysis of 100 patients
9. Carcinoma of unknown primary: Identification of a treatable subset?
10. Cancer of unknown primary: A retrospective study based on 109 patients
11. Delay by internists in obtaining diagnostic biopsies in patients with suspected cancer
12. Acups (adenocarcinoma of unknown primary site): A clinical and cost benefit analysis
13. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin
14. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma
15. Investigating the adenocarcinoma of unknown origin (Acup): A cost benefit analysis
16. Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin
17. An outcomes management program in gynecologic oncology
18. Unknown primary adenocarcinoma: Incidence of overinvestigation and natural history
19. Metastatic tumors of unknown origin
20. Metastases of unknown primary site
21. An analysis of 1 539 patients with cancer of unknown primary site
22. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck
23. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site
24. Treatment of patients with cancer of an unknown primary site
25. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: Favorable subsets of patients with unknown-primary carcinoma?
26. Metastatic cancer of unknown origin: Nonsquamous cell type
27. The CUP syndrome (carcinoma unknown primary)
28. Unknown primary tumors